BASE Inhibitors

BASE inhibitors refer to a class of chemical compounds that specifically inhibit the activity of the BASE (beta-site amyloid precursor protein cleaving enzyme) enzyme. BASE, also known as BACE1, is a protease involved in the cleavage of amyloid precursor protein (APP), which plays a significant role in various cellular processes, including protein maturation and trafficking. The inhibition of BASE can prevent or alter the cleavage of APP, impacting the downstream processing and accumulation of APP fragments. This class of inhibitors functions by binding to the active site of the BASE enzyme, blocking its catalytic activity and thus preventing its interaction with substrates such as APP.

BASE inhibitors are often used as biochemical tools in research to investigate the normal biological functions of the BASE enzyme beyond its role in APP processing. Inhibitors in this class have been instrumental in studying the broader proteolytic activity of BASE, as the enzyme is known to cleave several other proteins involved in cell signaling, neuronal communication, and cellular maintenance. By modulating BASE activity with inhibitors, researchers are able to delineate its role in various biochemical pathways and gain insight into how proteolytic processes are regulated at the molecular level. The use of BASE inhibitors has therefore become a critical component in exploring the cellular mechanisms controlled by this enzyme, contributing to our understanding of its broader functional impact within biological systems.